{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"renin-angiotensin-aldosterone-system-blocker-induced-angioedema","columns":[{"gene":"","key":"population-a6d80fa6661473ac8d80","label":"Renin-angiotensin-aldosterone system-blocker-induced angioedema","mondoId":"MONDO:0015057","onsetQualifier":null,"originColumnKey":"MONDO:0015057/ORPHA:100057","originalViews":[{"key":"MONDO:0015057/ORPHA:100057","label":"Renin-angiotensin-aldosterone system-blocker-induced angioedema","scopeLabel":"ORPHA:100057","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0124816cad5a2cc85ccabb1d816e04c68e034e8a3b7790a59ea1fe318284e52c","24c9c9899c7428e8ef2f350998390c925833b785a4baf3ee7085b2d9b236e334","2cfc9f916f1559265fb4ab904e323ae4f4fbda462950c4c184567dbbd7c7e64d","2ee9f8ac1f575d2d6ab397016cf6e59c04d9574e46b3b1a16a77c22e74dc7388","56360dc2d408fe25dc38d54f9b950bcd2e8f00a15daf657fae930606d63a5d73","63dfe455227929bd59968ed45a59c79ba1fd9f81d37a10fb192ce25bae57a594","6ef014af74cca1771706255ea2370f54f0ad7786fe20a751a51430b25b268fd2","7067b21f17adc4074b5f1173cafe175a893fdeb00cc60887290655462b442395","89b22651009d95fb2717e119ab77267904f1dda1a9316f83cd29cf4fadfd5fb4","99cbed6589aabdd27ed8608f95782cc17c139d2d11a7352464e43f4a01991b30","9e044a4a1a2530bfdabc26936d7b9a9cdc81dd989082f94b0c6c7734f8cfb58e","bc7f79b7baa04e71a86e704cde4e844f1017fbeb6f37eb100de38b39dac59942","c61a9cf87faaaecb90ab9a9371eca6ddcad765876fe7d255a71eb4b62c5aafcf"],"recordQualifiers":{},"scopeLabel":"ORPHA:100057","sourceIds":["ORPHA:100057"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-a6d80fa6661473ac8d80"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0025018","HP:0100665","HP:0010783","HP:0000282","HP:0012027","HP:0100540","HP:0011855"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":13,"sourceGroups":{"orphanet":13}},"features":[{"hpoId":"HP:0025018","label":"Abnormal capillary physiology","primary":true},{"hpoId":"HP:0100665","label":"Angioedema","primary":true},{"hpoId":"HP:0010783","label":"Erythema","primary":true},{"hpoId":"HP:0000282","label":"Facial edema","primary":true},{"hpoId":"HP:0012027","label":"Laryngeal edema","primary":true},{"hpoId":"HP:0100540","label":"Palpebral edema","primary":true},{"hpoId":"HP:0011855","label":"Pharyngeal edema","primary":true},{"hpoId":"HP:0000989","label":"Pruritus","primary":false},{"hpoId":"HP:0002098","label":"Respiratory distress","primary":false},{"hpoId":"HP:0031244","label":"Swollen lip","primary":false},{"hpoId":"HP:0040315","label":"Tongue edema","primary":false},{"hpoId":"HP:0002781","label":"Upper airway obstruction","primary":false},{"hpoId":"HP:0001025","label":"Urticaria","primary":false}],"ledeHtml":"Renin-angiotensin-aldosterone system (RAAS)-blocker induced angioedema (RAE) is a type of acquired angioedema (AAE) characterized by acute edema in subcutaneous tissues, viscera and/or the upper airway.","mondoId":"MONDO:0015057","node":{"canonicalSlug":"renin-angiotensin-aldosterone-system-blocker-induced-angioedema","comparisons":[{"documentSha256":"d9e79e952302ba67db99657bdd5b0b2db4cb199a3dd15cb24dc279d3711b56b4","key":"legacy-acquired-angioedema","kind":"legacy","label":"acquired angioedema","memberIds":["MONDO:0015057","MONDO:0019624"],"mondoId":"MONDO:0019624","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/acquired-angioedema.d9e79e952302ba67db99657bdd5b0b2db4cb199a3dd15cb24dc279d3711b56b4.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"renin-angiotensin-aldosterone system-blocker-induced angioedema","paragraphs":["Renin-angiotensin-aldosterone system (RAAS)-blocker induced angioedema (RAE) is a type of acquired angioedema (AAE) characterized by acute edema in subcutaneous tissues, viscera and/or the upper airway."],"scope":"exact","source":"MONDO","upstream":"Orphanet:100057","url":"https://monarchinitiative.org/MONDO:0015057"},"ownColumnKeys":["population-a6d80fa6661473ac8d80"],"publication":"published","relationships":[{"kind":"parent","label":"acquired angioedema","mondoId":"MONDO:0019624","slug":"acquired-angioedema"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/16936"}],"translation":"published"},"records":[{"frequencyKind":"range","key":"0124816cad5a2cc85ccabb1d816e04c68e034e8a3b7790a59ea1fe318284e52c","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:100057","disease_name":"Renin-angiotensin-aldosterone system-blocker-induced angioedema","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002098","is_excluded":false,"label":"Respiratory distress","onset_id":null,"reference":"ORPHA:100057","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"24c9c9899c7428e8ef2f350998390c925833b785a4baf3ee7085b2d9b236e334","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:100057","disease_name":"Renin-angiotensin-aldosterone system-blocker-induced angioedema","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001025","is_excluded":true,"label":"Urticaria","onset_id":null,"reference":"ORPHA:100057","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2cfc9f916f1559265fb4ab904e323ae4f4fbda462950c4c184567dbbd7c7e64d","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:100057","disease_name":"Renin-angiotensin-aldosterone system-blocker-induced angioedema","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010783","is_excluded":false,"label":"Erythema","onset_id":null,"reference":"ORPHA:100057","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2ee9f8ac1f575d2d6ab397016cf6e59c04d9574e46b3b1a16a77c22e74dc7388","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:100057","disease_name":"Renin-angiotensin-aldosterone system-blocker-induced angioedema","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031244","is_excluded":false,"label":"Swollen lip","onset_id":null,"reference":"ORPHA:100057","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"56360dc2d408fe25dc38d54f9b950bcd2e8f00a15daf657fae930606d63a5d73","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:100057","disease_name":"Renin-angiotensin-aldosterone system-blocker-induced angioedema","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000989","is_excluded":true,"label":"Pruritus","onset_id":null,"reference":"ORPHA:100057","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"63dfe455227929bd59968ed45a59c79ba1fd9f81d37a10fb192ce25bae57a594","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:100057","disease_name":"Renin-angiotensin-aldosterone system-blocker-induced angioedema","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0040315","is_excluded":false,"label":"Tongue edema","onset_id":null,"reference":"ORPHA:100057","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6ef014af74cca1771706255ea2370f54f0ad7786fe20a751a51430b25b268fd2","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:100057","disease_name":"Renin-angiotensin-aldosterone system-blocker-induced angioedema","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0025018","is_excluded":false,"label":"Abnormal capillary physiology","onset_id":null,"reference":"ORPHA:100057","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7067b21f17adc4074b5f1173cafe175a893fdeb00cc60887290655462b442395","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:100057","disease_name":"Renin-angiotensin-aldosterone system-blocker-induced angioedema","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0100665","is_excluded":false,"label":"Angioedema","onset_id":null,"reference":"ORPHA:100057","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"89b22651009d95fb2717e119ab77267904f1dda1a9316f83cd29cf4fadfd5fb4","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:100057","disease_name":"Renin-angiotensin-aldosterone system-blocker-induced angioedema","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002781","is_excluded":false,"label":"Upper airway obstruction","onset_id":null,"reference":"ORPHA:100057","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"99cbed6589aabdd27ed8608f95782cc17c139d2d11a7352464e43f4a01991b30","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:100057","disease_name":"Renin-angiotensin-aldosterone system-blocker-induced angioedema","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011855","is_excluded":false,"label":"Pharyngeal edema","onset_id":null,"reference":"ORPHA:100057","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9e044a4a1a2530bfdabc26936d7b9a9cdc81dd989082f94b0c6c7734f8cfb58e","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:100057","disease_name":"Renin-angiotensin-aldosterone system-blocker-induced angioedema","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100540","is_excluded":false,"label":"Palpebral edema","onset_id":null,"reference":"ORPHA:100057","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bc7f79b7baa04e71a86e704cde4e844f1017fbeb6f37eb100de38b39dac59942","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:100057","disease_name":"Renin-angiotensin-aldosterone system-blocker-induced angioedema","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012027","is_excluded":false,"label":"Laryngeal edema","onset_id":null,"reference":"ORPHA:100057","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c61a9cf87faaaecb90ab9a9371eca6ddcad765876fe7d255a71eb4b62c5aafcf","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:100057","disease_name":"Renin-angiotensin-aldosterone system-blocker-induced angioedema","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000282","is_excluded":false,"label":"Facial edema","onset_id":null,"reference":"ORPHA:100057","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0015057\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:100057</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Renin-angiotensin-aldosterone system (RAAS)-blocker induced angioedema (RAE) is a type of acquired angioedema (AAE) characterized by acute edema in subcutaneous tissues, viscera and/or the upper airway.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0015057\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"renin-angiotensin-aldosterone-system-blocker-induced-angioedema","sourceDocuments":[{"name":"MONDO: renin-angiotensin-aldosterone system-blocker-induced angioedema","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0015057"}],"sourceNote":"","synonyms":["AEACEI","Raas-blocker-induced angioedema","Raas-blocker-induced angioneurotic edema","Raas-blocker-induced angioneurotic oedema","RAE","reactive angioendotheliomatosis","renin-angiotensin-aldosterone system-blocker-induced angioneurotic edema","renin-angiotensin-aldosterone system-blocker-induced angioneurotic oedema"],"takeawayHtml":"","title":"renin-angiotensin-aldosterone system-blocker-induced angioedema"},"schemaVersion":1}
